Coronary Embolism After Transcatheter Aortic Valve Replacement—Case Series and Review of Literature

Akuka, Aviram; Landes, Uri; Manevich, Lisa; Rubinshtein, Ronen; Danenberg, Haim D.

doi:10.1016/j.amjcard.2023.07.137

Cited by 2 publications

(2 citation statements)

References 56 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The basic mechanism leading to myocardial ischemia is rupture of the atherosclerotic plaque in the coronary arteries and the resulting thrombosis [ 56 ]. Other mechanisms of myocardial ischemia resulting from coronary artery pathology include coronary artery spasm [ 57 ] or dissection [ 58 ], as well as coronary embolism [ 59 ]. Ischemic myocardial damage may also result from disproportions between oxygen supply and demand due to conditions such as bradyarrhythmia [ 60 ], tachyarrhythmia [ 61 ], poorly controlled hypertension resulting in left ventricular hypertrophy [ 62 ], respiratory failure [ 63 ], hypotension [ 64 ], shock (different types, both cardiogenic and non-cardiogenic) [ 65 , 66 , 67 ], or severe anemia [ 68 ].…”

Section: Cardiac Troponin Blood Level In Acute Cardiovascular Eventsmentioning

confidence: 99%

Cardiac Troponin Serum Concentration Measurement Is Useful Not Only in the Diagnosis of Acute Cardiovascular Events

Jakubiak

2024

JPM

View full text Add to dashboard Cite

Cardiac troponin serum concentration is the primary marker used for the diagnosis of acute coronary syndrome. Moreover, the measurement of cardiac troponin concentration is important for risk stratification in patients with pulmonary embolism. The cardiac troponin level is also a general marker of myocardial damage, regardless of etiology. The purpose of this study is to conduct a literature review and present the most important information regarding the current state of knowledge on the cardiac troponin serum concentration in patients with chronic cardiovascular disease (CVD), as well as on the relationships between cardiac troponin serum concentration and features of subclinical cardiovascular dysfunction. According to research conducted to date, patients with CVDs, such as chronic coronary syndrome, chronic lower extremities’ ischemia, and cerebrovascular disease, are characterized by higher cardiac troponin concentrations than people without a CVD. Moreover, the literature data indicate that the concentration of cardiac troponin is correlated with markers of subclinical dysfunction of the cardiovascular system, such as the intima–media thickness, pulse wave velocity, ankle–brachial index, coronary artery calcium index (the Agatston score), and flow-mediated dilation. However, further research is needed in various patient subpopulations and in different clinical contexts.

show abstract

Section: Cardiac Troponin Blood Level In Acute Cardiovascular Eventsmentioning

confidence: 99%

Cardiac Troponin Serum Concentration Measurement Is Useful Not Only in the Diagnosis of Acute Cardiovascular Events

Jakubiak

2024

JPM

View full text Add to dashboard Cite

show abstract

“…A 23 mm Sapiens 3 bioprosthesis was selected due to the high risk of paravalvular leakage resulting from severe calci cation in the LVOT and aortic valve (3,4). Pre-dilation with a 22 mm balloon was performed, and the nal positioning and valve implantation were carried out using the Philips HeartNavigator CT software (Figure 1-I and 1-J), with no paravalvular leakage detected.…”

Section: Full Textmentioning

confidence: 99%

Acute obstruction of the right coronary ostium after Transcatheter Aortic Valve Replacement. Is it time to enhance coronary obstruction risk prediction?

Garcia-Garcia,

Morales-Portano,

Andrade-Cuellar

et al. 2023

Preprint

View full text Add to dashboard Cite

Transcatheter aortic valve replacement (TAVR) is a well-established therapy for aortic stenosis, known for its safety and efficacy across a spectrum of patient risks compared to conventional aortic valve replacement (AVR). Despite its advantages, complications have been identified during or after the procedure. In a case involving a 72-year-old man with multiple comorbidities and severe aortic stenosis, pre-procedural planning revealed factors suggesting a higher risk for complications, such as calcifications in the ascending thoracic aorta, aortic valve, and left ventricular outflow tract (LVOT). The patient was considered at low risk for coronary obstruction. However, during TAVR with a 23 mm Sapiens 3 bioprosthesis, the patient experienced sudden dyspnea and chest pain. Coronary angiography revealed a contrast defect in the right coronary artery ostium, leading to immediate angioplasty, which was successful. While pre-procedural protection was deemed unnecessary in this case, it highlights the importance of considering factors beyond coronary height, such as calcium distribution and valve length, in predicting and preventing potential occlusion of coronary ostia during TAVR. Improved risk prediction is crucial in mitigating the occurrence of life-threatening complications.

show abstract

Coronary Embolism After Transcatheter Aortic Valve Replacement—Case Series and Review of Literature

Cited by 2 publications

References 56 publications

Cardiac Troponin Serum Concentration Measurement Is Useful Not Only in the Diagnosis of Acute Cardiovascular Events

Cardiac Troponin Serum Concentration Measurement Is Useful Not Only in the Diagnosis of Acute Cardiovascular Events

Acute obstruction of the right coronary ostium after Transcatheter Aortic Valve Replacement. Is it time to enhance coronary obstruction risk prediction?

Contact Info

Product

Resources

About